NEW YORK, Jan 30 – Illumina said Tuesday its revenue crossed the $1 million mark in 2000, but expenses rocketed as the company stepped up R&D spending.

For the year, publicly traded Illumina, a maker of microarray technologies, posted revenues of $1.3 million, compared with $474,000 in 1999.